← Back to Overview

Impact of preoperative immunosuppressive agents on postoperative outcomes in Crohn’s disease

All Citations — 115 total

With PDF (96)
  1. GW Moran, M Gordon, V Sinopolou, SJ Radford…. British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025. Gut. 2025. doi:10.1136/flgastro-2025-103425.
    IF 26.2PDF
  2. CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith…. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019. doi:10.1136/gutjnl-2019-318484corr1 PMID:33674339.
    IF 26.2PDF
  3. BL Cohen, P Fleshner, SV Kane, HH Herfarth…. Prospective cohort study to investigate the safety of preoperative tumor necrosis factor inhibitor exposure in patients with inflammatory bowel disease undergoing intra …. Gastroenterology. 2022. doi:10.1053/j.gastro.2022.03.057 PMID:35413359.
    IF 25.9PDF
  4. PL Stoner, A Kamel, F Ayoub, S Tan…. Perioperative care of patients with inflammatory bowel disease: focus on nutritional support. Gastroenterology …. 2018. doi:10.1155/2018/7890161 PMID:30344603.
    IF 25.9PDF
  5. M Aziz, H Haghbin, S Sharma, R Fatima…. Safety of bariatric surgery in patients with inflammatory bowel disease: A systematic review and meta‐analysis. Clinical …. 2020. doi:10.1007/s11695-020-04729-4.
    IF 12.2PDF
  6. CCY Law, C Bell, D Koh, Y Bao…. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database …. 2020. doi:10.1093/ibd/izaa020.
    IF 9.4PDF
  7. Y Li, L Stocchi, B Shen, X Liu…. Salvage surgery after failure of endoscopic balloon dilatation versus surgery first for ileocolonic anastomotic stricture due to recurrent Crohn's disease. Journal of British …. 2015. doi:10.1002/bjs.9906.
    IF 8.8PDF
  8. S Sebastian, JP Segal, C Hedin…. ECCO topical review: roadmap to optimal peri-operative care in IBD. Journal of Crohn's …. 2023.
    IF 8.7PDF
  9. A El-Hussuna, P Myrelid, SD Holubar…. Biological treatment and the potential risk of adverse postoperative outcome in patients with inflammatory bowel disease: an open-source expert panel review of the …. Crohn's & Colitis …. 2019. doi:10.1093/ecco-jcc/jjz203.808.
    IF 8.7PDF
  10. AL Lightner, F Grass, A Alsughayer…. Postoperative outcomes in ustekinumab-treated patients undergoing abdominal operations for Crohn's disease: single-center series. Crohn's & Colitis …. 2019. doi:10.1093/crocol/otz018.
    IF 8.7PDF
  11. W Huang, Y Tang, L Nong, Y Sun. Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: a meta-analysis of observational studies. Journal of Crohn's and Colitis. 2015. doi:10.1093/ecco-jcc/jju028.
    IF 8.7PDF
  12. P Waterland, T Athanasiou…. Post-operative abdominal complications in Crohn's disease in the biological era: systematic review and meta-analysis. World Journal of …. 2016. doi:10.4240/wjgs.v8.i3.274 PMID:27022455.
    IF 5.8PDF
  13. A Al-Janabi, ZZN Yiu. Biologics in psoriasis: updated perspectives on long-term safety and risk management. Psoriasis: Targets and Therapy. 2022. doi:10.2147/ptt.s328575.
    IF 5.7PDF
  14. S Zhang, Y Cao, Z Wang, H Liu, Y Teng, G Li, J Liu…. Fermented Sargassum fusiforme Mitigates Ulcerative Colitis in Mice by Regulating the Intestinal Barrier, Oxidative Stress, and the NF-κB Pathway. Foods. 2023. doi:10.3390/foods12101928 PMID:37238746.
    IF 5.1PDF
  15. F Grass, B Pache, D Martin, D Hahnloser…. Preoperative nutritional conditioning of Crohn's patients—systematic review of current evidence and practice. Nutrients. 2017. doi:10.3390/nu9060562 PMID:28587182.
    IF 5.0PDF
  16. S Lahes, C Fischer, AE Spiliotis, A Schulz…. Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn's disease patients. International Journal of …. 2022. doi:10.1007/s00384-022-04287-4 PMID:36441196.
    IF 4.9PDF
  17. E Lavorini, ME Allaix, CA Ammirati, M Astegiano…. Late is too late? Surgical timing and postoperative complications after primary ileocolic resection for Crohn's disease. International Journal of …. 2022. doi:10.1007/s00384-022-04125-7 PMID:35274184.
    IF 4.9PDF
  18. MS Zangenberg, N Horesh, U Kopylov…. Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review. International Journal of …. 2017. doi:10.1007/s00384-017-2915-4.
    IF 4.9PDF
  19. CCY Law, D Koh, Y Bao, V Jairath…. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease: a systematic review and meta-analysis. Inflammatory bowel …. 2020. doi:10.1093/ibd/izaa020 PMID:32047894.
    IF 4.3PDF
  20. BE Haac, A Nemirovsky, W Teeter…. Injury characteristics and outcomes of patients with inflammatory bowel disease after trauma: a propensity score matched analysis. Inflammatory bowel …. 2020. doi:10.1093/ibd/izz254 PMID:31633157.
    IF 4.3PDF
  21. TM Hansen, LE Targownik…. Management of biological therapy before elective inflammatory bowel disease surgeries. Inflammatory Bowel …. 2019. doi:10.1093/ibd/izz002 PMID:30794289.
    IF 4.3PDF
  22. K Diederen, L de Ridder, P van Rheenen…. Complications and disease recurrence after primary ileocecal resection in pediatric Crohn's disease: a multicenter cohort analysis. Inflammatory bowel …. 2017. doi:10.1097/MIB.0000000000000999 PMID:28079626.
    IF 4.3PDF
  23. CW Hicks, EC Wick, R Salvatori…. Perioperative corticosteroid management for patients with inflammatory bowel disease. Inflammatory bowel …. 2015. doi:10.1097/MIB.0000000000000185 PMID:25208109.
    IF 4.3PDF
  24. AL Lightner, B Shen. Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new" biological era". Gastroenterology Report. 2017. doi:10.1093/gastro/gow046 PMID:28852521.
    IF 4.2PDF
  25. S Gaines, S Hyoju, AJ Williamson…. Infliximab does not promote the presence of collagenolytic bacteria in a mouse model of colorectal anastomosis. Journal of …. 2020. doi:10.1007/s11605-019-04486-5 PMID:31898107.
    IF 4.1PDF
  26. M Abou Khalil, J Abou-Khalil, J Motter…. Immunosuppressed patients with Crohn's disease are at increased risk of postoperative complications: results from the ACS-NSQIP database. Journal of …. 2019. doi:10.1007/s11605-019-04186-0 PMID:30887300.
    IF 4.1PDF
  27. Y Li, L Stocchi, Y Rui, G Liu, E Gorgun…. Perioperative blood transfusion and postoperative outcome in patients with Crohn's disease undergoing primary ileocolonic resection in the “Biological Era”. Journal of …. 2015. doi:10.1007/s11605-015-2893-1 PMID:26286365.
    IF 4.1PDF
  28. SJ Koh, SN Hong, SK Park, BD Ye, KO Kim…. Korean clinical practice guidelines on biologics for moderate to severe Crohn's disease. Intestinal …. 2023. doi:10.5217/ir.2022.00029 PMID:36245343.
    IF 3.9PDF
  29. KM Lee, YS Kim, GS Seo, TO Kim…. Use of thiopurines in inflammatory bowel disease: a consensus statement by the Korean Association for the Study of Intestinal Diseases (KASID). Intestinal …. 2015. doi:10.5217/ir.2015.13.3.193 PMID:26130993.
    IF 3.9PDF
  30. KE Lee, AS Faye, S Vermeire…. Perioperative management of ulcerative colitis: a systematic review. Diseases of the Colon & …. 2022. doi:10.1097/dcr.0000000000002588.
    IF 3.7PDF
  31. AL Lightner, JD Vogel, JC Carmichael…. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the surgical management of Crohn's disease. Diseases of the Colon …. 2020. doi:10.1097/DCR.0000000000001716 PMID:32692069.
    IF 3.7PDF
  32. R Narang, T Hull, S Perrins, JS Garcia…. Should immunomodulation therapy alter the surgical management in patients with rectovaginal fistula and Crohn's disease?. Diseases of the Colon …. 2016. doi:10.1097/dcr.0000000000000614 PMID:27270520.
    IF 3.7PDF
  33. S Strong, SR Steele, M Boutrous…. Clinical practice guideline for the surgical management of Crohn's disease. Diseases of the Colon …. 2015. doi:10.1097/DCR.0000000000000450 PMID:26445174.
    IF 3.7PDF
  34. A Davila, R Magee, K France. A retrospective, single-center cohort study on complications after dental extractions in patients taking biologic agents. The Journal of the American Dental …. 2022. doi:10.1016/j.adaj.2022.07.009 PMID:36115715.
    IF 3.5PDF
  35. SC Levy, PL Johnson, CL Mullens…. Impact of Chronic Immunosuppression on Emergency General Surgery Outcomes. Journal of the …. 2023. doi:10.1097/XCS.0000000000001855 PMID:41696911.
    IF 3.4PDF
  36. AB Quaresma, T Yamamoto…. Biologics and surgical outcomes in Crohn's disease: is there a direct relationship?. Therapeutic Advances in …. 2020. doi:10.1177/1756284820931738 PMID:32728389.
    IF 3.4PDF
  37. TL Lin, IL Chen, WH Lai, YJ Chen, KH Wu…. Predicting major surgical complications in intensive care units and in-hospital mortality of patients from the emergency room: A retrospective single-center study. Science …. 2025. doi:10.1177/00368504251406913 PMID:41417756.
    IF 2.9PDF
  38. S Horgan, J Hegarty, E Andrews…. Impact of a quality improvement intervention on the incidence of surgical site infection in patients undergoing colorectal surgery: Pre‐test–post‐test design. Journal of clinical …. 2023. doi:10.1111/jocn.16690.
    IF 2.9PDF
  39. N Horesh, MR Freund, Z Garoufalia, R Gefen…. Biological therapy prior to repeat ileocolic resection in Crohn's disease can reduce the postoperative complication rate. Techniques in …. 2023. doi:10.1007/s10151-022-02702-0.
    IF 2.9PDF
  40. K Cira, MC Weber, D Wilhelm, H Friess…. The effect of anti-tumor necrosis factor-alpha therapy within 12 weeks prior to surgery on postoperative complications in inflammatory bowel disease: a …. Journal of Clinical …. 2022. doi:10.3390/jcm11236884 PMID:36498459.
    IF 2.9PDF
  41. RB Nones, PR Fleshner, NSF Queiroz…. Therapeutic drug monitoring of biologics in IBD: essentials for the surgical patient. Journal of Clinical …. 2021. doi:10.3390/jcm10235642 PMID:34884344.
    IF 2.9PDF
  42. G Pellino, F Selvaggi, G Ghezzi, D Corona…. A think tank of the Italian society of colorectal surgery (SICCR) on the surgical treatment of inflammatory bowel disease using the Delphi method: Crohn's disease. Techniques in …. 2015. doi:10.1007/s10151-015-1368-4.
    IF 2.9PDF
  43. X Luo, H Zhou, S Wang, J Xiong, C Mo…. A benzoxazole derivative PO‐296 inhibits T lymphocyte proliferation by the JAK3/STAT5 signal pathway. Journal of cellular …. 2019. doi:10.1002/jcb.28195.
    IF 2.8PDF
  44. AA Simard, S Kotamraju, JR DeFazio…. Role of ileal diversion in pediatric inflammatory bowel disease. Journal of Pediatric …. 2024. doi:10.1002/jpn3.12331.
    IF 2.7PDF
  45. A Wallhuss, J Ottosson, Y Cao, E Andersson…. Outcomes of bariatric surgery for patients with prevalent inflammatory bowel disease: a nationwide registry-based cohort study. Surgery. 2023. doi:10.1016/j.surg.2023.04.059 PMID:37263879.
    IF 2.7PDF
  46. SH Emile, MR Freund, N Horesh, Z Garoufalia…. Risk factors and predictors of 30-day complications and conversion to open surgery after repeat ileocolic resection of Crohn's disease. Surgical …. 2023. doi:10.1007/s00464-022-09557-4.
    IF 2.7PDF
  47. I Sapci, M Zutshi, N Akeel, T Hull. What are the outcomes in patients referred to a tertiary referral centre for Crohn's rectovaginal fistula surgery?. Colorectal Disease. 2023. doi:10.1111/codi.16660.
    IF 2.7PDF
  48. JB Mitsuya, R Gonzalez, R Thomas…. The effect of biologics on postoperative complications in children with inflammatory bowel disease and bowel resection. Journal of pediatric …. 2019. doi:10.1097/mpg.0000000000002159.
    IF 2.7PDF
  49. M Carvello, EJ de Groof…. Single port laparoscopic ileocaecal resection for Crohn's disease: a multicentre comparison with multi‐port laparoscopy. Colorectal …. 2018. doi:10.1111/codi.13777.
    IF 2.7PDF
  50. PI Abbas, ML Peterson, SC Fallon, ME Lopez…. Evaluating the impact of infliximab use on surgical outcomes in pediatric Crohn's disease. Journal of Pediatric …. 2016. doi:10.1016/j.jpedsurg.2016.02.023 PMID:26944181.
    IF 2.7PDF
  51. EJ de Groof. Surgery and medical therapy in Crohn's disease. Colorectal disease. 2016.
    IF 2.7PDF
  52. F Schnitzler, C Tillack-Schreiber, D Szokodi, I Braun…. Safety of perioperative treatment with biologics in patients with inflammatory bowel disease undergoing bowel surgery: Experience from a large urban center. Plos one. 2024. doi:10.1371/journal.pone.0290887 PMID:38236926.
    IF 2.6PDF
  53. M Carter, IIP Lim. Surgical management of pediatric Crohn's disease. Seminars in pediatric surgery. 2024. doi:10.1016/j.sempedsurg.2024.151401 PMID:38615423.
    IF 2.5PDF
  54. CA Schad, BE Haac, RK Cross, A Syed…. Early postoperative anti-TNF therapy does not increase complications following abdominal surgery in Crohn's disease. Digestive diseases and …. 2019. doi:10.1007/s10620-019-5476-2.
    IF 2.5PDF
  55. K Zaghiyan, D McGovern, P Fleshner. Should biologic agents be stopped before surgery for inflammatory bowel disease?. Expert Review of …. 2015. doi:10.1586/17474124.2015.975208 PMID:25366845.
    IF 2.5PDF
  56. RRO Saidy, YM Callister, L Dittrich, D Eurich…. Safety and outcome of elective synthetic mesh repair for incisional ventral hernias in immunosuppressed patients–a retrospective propensity-score-matched analysis. Hernia. 2025. doi:10.1007/s10029-025-03273-3 PMID:39992451.
    IF 2.4PDF
  57. N Siegel, S DiBrito, T Ishaque, AB Kernodle…. Open inguinal hernia repair outcomes in liver transplant recipients versus patients with cirrhosis. Hernia. 2021. doi:10.1007/s10029-020-02290-8.
    IF 2.4PDF
  58. W Zhou, Q Cao, W Qi, Y Xu, W Liu…. Prognostic nutritional index predicts short‐term postoperative outcomes after bowel resection for Crohn's disease. Nutrition in Clinical …. 2017. doi:10.1177/0884533616661844 PMID:27566600.
    IF 2.2PDF
  59. P Myrelid, M Soop, BD George. Surgical planning in penetrating abdominal Crohn's disease. Frontiers in Surgery. 2022. doi:10.3389/fsurg.2022.867830 PMID:35592128.
    IF 1.8PDF
  60. Y Duan, Y Liu, Y Li. Previous intestinal resection is Associated with Postoperative complications in Crohn's Disease: a Cohort Study. Gastroenterology Research and Practice. 2020. doi:10.1155/2020/2194382 PMID:33014037.
    IF 1.4PDF
  61. Y Li, L Zuo, W Zhu, J Gong, W Zhang, L Gu, Z Guo…. Role of exclusive enteral nutrition in the preoperative optimization of patients with Crohn's disease following immunosuppressive therapy. Medicine. 2015. doi:10.1097/MD.0000000000000478 PMID:25654387.
    IF 1.4PDF
  62. G Shroff. Human embryonic stem cell therapy in Crohn's disease: a case report. The American Journal of Case Reports. 2016. doi:10.12659/ajcr.896512 PMID:26923312.
    IF 0.7PDF
  63. RG Landmann. Surgical management of anastomotic leak following colorectal surgery. Seminars in colon and rectal surgery. 2014. doi:10.1053/j.scrs.2014.05.001.
    IF 0.5PDF
  64. T Eskazan, I Hatemi. Surgical Treatment in Inflammatory Bowel Disease. Journal of Enterocolitis. 2025.
    PDF
  65. RK Mowlah, J Soldera. Risk and management of post-operative infectious complications in inflammatory bowel disease: A systematic review. World Journal of Gastrointestinal …. 2023. doi:10.4240/wjgs.v15.i11.2579.
    PDF
  66. CC Lin, HH Lin, HC Chen, NC Chen…. Perioperative optimization of Crohn's disease. Annals of …. 2023. doi:10.1002/ags3.12621 PMID:36643355.
    PDF
  67. M Doane - 2023 - anzca.intersearch.com.au. Australasian anaesthesia 2023: invited papers and selected continuing education lectures. 2023. 2023. doi:10.60115/11055/1178.
    PDF
  68. TM Nguyen, J Szental, D Bramley. A narrative review of the perioperative management of DMARDs. Australasian Anaesthesia. 2023. doi:10.60115/11055/1194.
    PDF
  69. A Micalef, M Polizzi, G Maconi…. Risk factors and therapeutic options for postoperative intra-abdominal septic complication in Crohn's disease. Open J Clin Med …. 2023.
    PDF
  70. Z Mehmedovic - South-East European Endo-Surgery Journal, 2023 - seees.aesbh.org. Surgical Treatment of Crohn's Disease. South-East European Endo-Surgery Journal. 2023.
    PDF
  71. B Oller Bresca - 2023 - ddd.uab.cat. Història natural i monitoratge de la recurrència postquirúrgica a la malatia de Crohn. 2023. 2023.
    PDF
  72. F Cañete - 2022 - ddd.uab.cat. Factores de riesgo y optimización del manejo de la recurrencia postquirúrgica en la enfermedad de Crohn. 2022. 2022.
    PDF
  73. FC Cañete Pizarro - 2022 - tdx.cat. Factores de riesgo y optimización del manejo de la recurrencia postquirúrgica en la enfermedad de Crohn. 2022. 2022.
    PDF
  74. CM Sakurai Kimura, A Scanavini Neto…. Abdominal surgery in Crohn's disease: risk factors for complications. Inflammatory Intestinal …. 2021. doi:10.1159/000510999 PMID:33850835.
    PDF
  75. MDM Arranz, CS Ferrer, VLL de Osorio…. Resultados de la cirugía en enfermedad inflamatoria intestinal: experiencia en un centro de atención terciaria. Acta …. 2021.
    PDF
  76. D Dillane, R Snelgrove - Preoperative Assessment: A Case-Based …, 2021 - Springer. Crohn's Disease. Preoperative Assessment: A Case-Based …. 2021. doi:10.1186/s12876-025-04305-z PMID:41063000.
    PDF
  77. A Gklavas, A Poulaki, D Dellaportas…. Risk factors for postoperative complications after elective ileocolic resection for Crohn's disease: a retrospective study. Annals of …. 2020. doi:10.20524/aog.2020.0533 PMID:33162741.
    PDF
  78. F Juliao-Baños, LFP Ovalle, WO Regino…. Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta. Revista colombiana de …. 2020. doi:10.22516/25007440.637.
    PDF
  79. F Juliao-Baños, LF Pineda, W Otero-Regino…. Clinical practice guidelines for the treatment of Crohn's disease in the adult population. Revista colombiana de …. 2020.
    PDF
  80. CMSKA Scanavini, NNSFQ Natally, HMGMC Marcelo… - 2020. Abdominal Surgery in Crohn's Disease: Risk Factors for Complications. 2020. 2020. doi:10.1159/000510999 PMID:33850835.
    PDF
  81. M Guasch Marcé - 2020 - ddd.uab.cat. Relació entre la disponibilitat de tractaments biològics i la necessitat i complicacions de la cirurgia en la malaltia inflamatòria intestinal. 2020. 2020.
    PDF
  82. M de Lourdes Setsuko Ayrizono…. Biological therapy for inflammatory bowel diseases: screening prior to initiating and how to proceed when surgery is necessary. Biological Therapy for …. 2020. doi:10.5772/intechopen.90001.
    PDF
  83. MLS Ayrizono, PSP Oliveira…. Biological Therapy for Inflammatory Bowel Diseases: Screening Prior to Initiating and How to Proceed When Surgery Is Necessary. Biological Therapy for …. 2019. doi:10.5772/intechopen.90001.
    PDF
  84. A El-Hussuna. Surgical Intervention in Patients with IBD: Be Prepared!. EC Gastroenterology and Digestive System. 2019.
    PDF
  85. A El-Hussuna - 2018 - vbn.aau.dk. Effects of anti-tumour necrosis factor-α agents on postoperative outcome in patients with Crohn's disease undergoing bowel resection. 2018. 2018.
    PDF
  86. RR Cima, JH Pemberton. Surgical Management of Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis: From …. 2017. doi:10.1007/978-3-319-33703-6_50.
    PDF
  87. KT Crowell, E Messaris. Risk factors and implications of anastomotic complications after surgery for Crohn's disease. World journal of gastrointestinal …. 2015. doi:10.4240/wjgs.v7.i10.237 PMID:26523211.
    PDF
  88. KL Mathis, JH Pemberton. New developments in colorectal surgery. Current Opinion in Gastroenterology. 2015. doi:10.1097/mog.0000000000000138.
    PDF
  89. ВЛ РивкинΕ, ЛЛ Капуллер. Неспецифический язвенный колит и болезнь Крона толстой кишки–одно заболевание?. CONSILIUM MEDICUM. 2015.
    PDF
  90. A El-Hussuna - academia.edu. Mini Review Surgical Intervention in Patients with IBD: Be Prepared!. academia.edu.
    PDF
  91. MW Douie, T Pinkney, MR Guy, J Limdi, B Hawthorne… - ncepod.org.uk. Crohn's Disease. ncepod.org.uk.
    PDF
  92. B Benjamin, RM Amine, BJ Louis, H Xavier… - Available at SSRN … - papers.ssrn.com. AntiTNF α: Risk Factor of Major Complications Following Ileocolic Resection for Crohn's Disease. Available at SSRN …. doi:10.2139/ssrn.3529617.
    PDF
  93. M Eberhardson, U i Linköping - svenskgastroenterologi.se. Nationell riktlinje. svenskgastroenterologi.se.
    PDF
  94. TDKKK Klin - svenskgastroenterologi.se. Nationell riktlinje. svenskgastroenterologi.se.
    PDF
  95. B Benjamin. Analyse multivariée des facteurs de risque de complications graves après résection iléocolique pour maladie de Crohn.
    PDF
  96. AK AK - bip.aotm.gov.pl. Produkt leczniczy Remsima®(infliksymab, proszek do sporządzania koncentratu roztworu do infuzji) stosowany w leczeniu podtrzymującym (do 12 miesięcy) …. bip.aotm.gov.pl.
    PDF
Without PDF (19)
  1. K France - Contemporary Dental Pharmacology: Evidence-Based …, 2024 - Springer. Biologic Agents. Contemporary Dental Pharmacology: Evidence-Based …. 2024.
  2. ЮА Шелыгин, ВТ Ивашкин, СИ Ачкасов…. Клинические рекомендации. Болезнь Крона (К50), взрослые. …. 2023.
  3. ЮА Шелыгин, ВТ Ивашкин, СИ Ачкасов…. Болезнь Крона (К50), взрослые. …. 2023.
  4. A Andalib. Sleeve Gastrectomy in Immunocompromised Patients. Laparoscopic Sleeve Gastrectomy. 2021. doi:10.1007/978-3-030-57373-7_16.
  5. P Reuken, A Stallmach - Chronisch-entzündliche Darmerkrankungen: in …, 2020 - Springer. Infektionen bei CED. Chronisch-entzündliche Darmerkrankungen: in …. 2020.
  6. HT Kani, B Shen. Indications and preoperative medical management of ulcerative colitis patients undergoing pouch surgery. Pouchitis and Ileal Pouch Disorders. 2019. doi:10.1016/b978-0-12-809402-0.00002-2.
  7. A El-Hussuna, MS Zangenberg - Best Practice-Gastroenterologi, 2019 - vbn.aau.dk. Præ-operativ optimering af patienter med inflammatorisk tarmsygdom. Best Practice-Gastroenterologi. 2019.
  8. K Umanskiy, N Hyman. Anastomotic complications. The ASCRS Textbook of Colon and Rectal …. 2016. doi:10.1007/978-3-030-66049-9_10.
  9. R Muldoon, AJ Herline. Crohn's disease: surgical management. The ASCRS textbook of colon and rectal surgery. 2016.
  10. 吴现瑞， 刘炫辉， 兰平. 炎性肠病手术并发症的防范与处理. 中华胃肠外科杂志. 2016.
  11. 张渝， 吴小平. 克罗恩病术后胃肠道相关并发症研究及诊疗现状. 中国医师杂志. 2016.
  12. 葛媛媛， 李毅， 龚剑峰， 郭振， 曹磊， 朱维铭， 黎介寿. 克罗恩病的营养支持治疗. 胃肠病学. 2016.
  13. 吴现瑞， 刘炫辉， 兰平. 炎性肠病手术并发症的防范与处理. 中华胃肠外科杂志. 2016.
  14. 张渝， 吴小平. 克罗恩病术后胃肠道相关并发症研究及诊疗现状. 中国医师杂志. 2016.
  15. 葛媛媛， 李毅， 龚剑峰， 郭振， 曹磊， 朱维铭， 黎介寿. 克罗恩病的营养支持治疗. 胃肠病学. 2016.
  16. BL Cohen - Anti-Tumor Necrosis Factor Therapy in Inflammatory …, 2015 - books.google.com. Risk of Post-Operative Infections with Anti-TNF Therapy. Anti-Tumor Necrosis Factor Therapy in Inflammatory …. 2015. doi:10.1159/000381596.
  17. 兰平， 胡品津， 朱维铭. 炎性肠病术后并发症危险因素及预防的专家意见 (2014· 广州). 中华胃肠外科杂志. 2015.
  18. BE Haac, A Nemirovsky, W Teeter, A Geyer, RT Birkett… - scholarlyworks.lvhn.org. Let us know how access to this document benefits yo u. scholarlyworks.lvhn.org.
  19. AL Lightner, JD Vogel, JC Carmichael, DS Keller… - journals.lww.com. 美国结直肠外科医师协会克罗恩病外科治疗的临床实践指南. journals.lww.com.